Antibody-drug conjugates targeted at human aspartyl (asparaginyl) β-hydroxylase

被引：0
|
作者：
Malhotra, Kanam [1 ]
Walker, Susan [1 ]
Fang, Chen [2 ]
Birthare, Karamveer [2 ]
Lebowitz, Michael S. [1 ]
Fuller, Steven [1 ]
Sesay, Muctarr [2 ]
Ghanbari, Hossein A. [1 ]
机构：
[1] Panacea Pharmaceut Inc, Gaithersburg, MD USA
[2] Goodwin Biotechnol Inc, Plantation, FL USA
来源：
MOLECULAR CANCER THERAPEUTICS | 2018年 / 17卷 / 01期
关键词：
D O I：
10.1158/1535-7163.TARG-17-B106
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B106
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Targeted Delivery of Cytotoxic NAMPT Inhibitors Using Antibody-Drug Conjugates
    Neumann, Christopher S.
    Olivas, Kathleen C.
    Anderson, Martha E.
    Cochran, Julia H.
    Jin, Steven
    Li, Fu
    Loftus, Luke, V
    Meyer, David W.
    Neale, Jason
    Nix, Jay C.
    Pittman, Paul G.
    Simmons, Jessica K.
    Ulrich, Michelle L.
    Waight, Andrew B.
    Wong, Abbie
    Zaval, Margo C.
    Zeng, Weiping
    Lyon, Robert P.
    Senter, Peter D.
    MOLECULAR CANCER THERAPEUTICS, 2018, 17 (12) : 2633 - 2642
  • [32] Targeted delivery of cytotoxic NAMPT inhibitors using antibody-drug conjugates
    Neumann, Christopher S.
    Olivas, Kathleen C.
    Waight, Andrew B.
    Meyer, David
    Loftus, Luke V.
    Zaval, Margo
    Anderson, Martha E.
    Jin, Steven
    Cochran, Julia H.
    Simmons, Jessica K.
    Pittman, Paul G.
    Lyon, Robert P.
    Senter, Peter D.
    CANCER RESEARCH, 2018, 78 (13)
  • [33] Antibody-drug conjugates: Promising and efficient tools for targeted cancer therapy
    Nasiri, Hadi
    Valedkarimi, Zahra
    Aghebati-Maleki, Leili
    Majidi, Jafar
    JOURNAL OF CELLULAR PHYSIOLOGY, 2018, 233 (09) : 6441 - 6457
  • [34] Targeted delivery of alcohol-containing payloads with antibody-drug conjugates
    Grier, Katja E.
    Hansen, Anders H.
    Haxvig, Christina S.
    Li, Xin
    Krigslund, Oliver
    Behrendt, Niels
    Engelholm, Lars H.
    Rossi, Fabio
    Sousa, Bebiana C.
    Harradence, Grant J.
    Camper, Nicolas
    Qvortrup, Katrine M.
    CHEMICAL COMMUNICATIONS, 2023, 59 (47) : 7240 - 7242
  • [35] Advances in antibody-drug conjugates: A new era of targeted cancer therapy
    Sau, Samaresh
    Alsaab, Hashem O.
    Kashaw, Sushi Kumar
    Tatiparti, Katyayani
    lyer, Arun K.
    DRUG DISCOVERY TODAY, 2017, 22 (10) : 1547 - 1556
  • [36] Development of HSPG2 targeted glycoengineered antibody-drug conjugates
    Li, Xiaolei
    Prabha, Swayam
    CANCER RESEARCH, 2024, 84 (06)
  • [37] Antibody-Drug Conjugates as a Targeted Therapeutic Approach Across Entities in Oncology
    Lordick, Florian
    Merz, Maximilian
    Buech, Eva
    Aigner, Achim
    DEUTSCHES ARZTEBLATT INTERNATIONAL, 2023, 120 (19): : 329 - +
  • [38] Antibody-Oligonucleotide Conjugates: A Twist to Antibody-Drug Conjugates
    Dugal-Tessier, Julien
    Thirumalairajan, Srinath
    Jain, Nareshkumar
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (04) : 1 - 17
  • [39] Radioimmunotherapy for acute myeloid leukemia targeting human aspartyl (asparaginyl) β-hydroxylase
    Lebowitz, Michael S.
    Revskaya, Ekaterina
    Malhotra, Kanam
    Shahlaee, Amir
    Fuller, Steven
    Baer, Maria R.
    Holtzman, Noa G.
    Emadi, Ashkan
    Dadachova, Ekaterina
    Ghanbari, Hossein A.
    CANCER RESEARCH, 2017, 77
  • [40] Isolation and engineering of biologically active human singlechain antibody fragments (SCFV) against human aspartyl (asparaginyl) β-hydroxylase.
    Yeung, A
    Finney, A
    Lebowitz, M
    Ghanbari, K
    Ghanbari, H
    Wittrup, D
    CLINICAL CANCER RESEARCH, 2003, 9 (16) : 6196S - 6196S
12345